Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
E M AmmarMohammed S Hassan

Abstract

Androgenic-anabolic steroids (AAS) are widely abused by athletes and this abuse has been associated with many serious circulatory events including sudden cardiac death, myocardial infarction and cardiac hypertrophy. The effect of chronic treatment for 16 weeks with testosterone (25mg(-1)kg(-1)week(-1)) and nandrolone (50mg(-1)kg(-1)week(-1)) on serum lipids of male hypercholesterolemic New Zealand rabbits was investigated. The responses of isolated rabbit aortic rings to some vasoconstrictors (epinephrine, serotonin and endothelin-1) and vasodilators (adenosine and sodium nitroprusside) were also measured after treatment. Testosterone and nandrolone significantly reduced HDL-cholesterol levels, potentiated vasoconstriction responses to epinephrine, serotonin and endothelin-1, and attenuated vasorelaxant responses to sodium nitroprusside in rabbits. Nandrolone also caused a significant increase in LDL-cholesterol levels. No significant changes in adenosine relaxation were found in rabbits. The results of the present study showed that the abuse of AAS in presence of hypercholesterolemia can enhance atherogenicity and vasospasm as well as attenuation of vasorelaxation. Therefore the abuse of AAS is harmful to the vascular system a...Continue Reading

Citations

Mar 9, 2011·Journal of Cardiovascular Pharmacology·Rabelais Tatchum-TalomDouglas S Martin
Nov 27, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Brian L StaufferChristopher A Desouza
Mar 5, 2009·European Journal of Medical Research·P KalkB Hocher
Nov 26, 2011·Canadian Journal of Physiology and Pharmacology·Tadeu Uggere AndradeNazaré Souza Bissoli
May 18, 2016·European Journal of Preventive Cardiology·Georgios A ChristouJohn A Goudevenos
Jun 28, 2016·Toxicology Letters·Christina TsitsimpikouAristidis M Tsatsakis
Nov 7, 2015·Toxicology Letters·Fotini VasilakiΑristidis M Tsatsakis
Jul 12, 2013·Journal of the American Heart Association·Michael J HerringRobert A Kloner
Dec 1, 2007·Journal of Addiction Medicine·Rinah T YamamotoMarc J Kaufman
Mar 19, 2019·European Journal of Sport Science·Georgios A ChristouKonstantinos A Christou
Mar 26, 2016·The Open Cardiovascular Medicine Journal·Amos TamboNikolai P Pace
Jan 11, 2012·Sports Medicine·Peter AngellKeith George
Jan 1, 2014·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Patrícia de S RossignoliAgnaldo B Chies
May 14, 2020·BMC Neurology·Mayu IshiguroNobutaka Hattori
Mar 19, 2021·Cardiovascular Research·Saraschandra VallabhajosyulaVirginia M Miller
Feb 19, 2011·Journal of Cardiothoracic and Vascular Anesthesia·Robert J Deegan, William R Furman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

The Journal of Steroid Biochemistry and Molecular Biology
Abram BeutelRuy Ribeiro Campos
Toxicological Sciences : an Official Journal of the Society of Toxicology
Benjamin D PhillisRodney J Irvine
European Journal of Applied Physiology
Pedro P Pereira-JuniorJosé H M Nascimento
© 2022 Meta ULC. All rights reserved